COGENTIN Side Effects

6656803-6 | Abnormal Behaviour, Agitation, Blood Pressure Diastolic Decreased, Confusional State, Depressed Level Of Consciousness, Gastrointestinal Sounds Abnormal, Heart Rate Increased, Incoherent
on Feb 24, 2010 Female patient from UNITED STATES , 38 years of age, was diagnosed with abnormal behaviour and was treated with Cogentin (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, agitation, blood pressure diastolic decreased, confusional state, depressed level of consciousness, gastrointestinal sounds abnormal, heart rate increased, incoherent. Cogentin dosage: Prn. During the same period patient was treated with GEODON (View Geodon Review and Geodon Label ). Patient was hospitalized.

6546016-0 | Hallucination
Patient was taking Cogentin (View Usage). Patient had the following side effects: hallucination on Jan 21, 2010 from UNITED STATES Additional patient health information: Female patient , 49 years of age, weighting 192.0 lb, was diagnosed with tardive dyskinesia and. Cogentin dosage: 1mg Tablet 3 Times Daily Po. Patient was hospitalized.

6338464-9 | Affective Disorder, Amnesia, Blood Growth Hormone Decreased, Cognitive Disorder, Post-traumatic Stress Disorder, Tardive Dyskinesia
Adverse event was reported on Aug 21, 2009 by a Male patient taking Cogentin (View Usage) (Dosage: 2 Mg; 1x; Im) . Location: UNITED STATES , 31 years of age, After Cogentin was administered, patient had the following side effects: affective disorder, amnesia, blood growth hormone decreased, cognitive disorder, post-traumatic stress disorder (What is post-traumatic stress disorder?), tardive dyskinesia. During the same period patient was treated with HALDOL (10 Mg; Im) (View Haldol Review and Haldol Label ), ATIVAN (2 Mg; Im) (View Ativan Review and Ativan Label ), PROZAC (View Prozac Review and Prozac Label ). Patient was hospitalized.

6219411-7 | Accommodation Disorder, Diplopia, Pupillary Reflex Impaired, Strabismus, Visual Acuity Reduced
on May 22, 2009 Female patient from UNITED STATES , 29 years of age, was diagnosed with depression (What is depression?), schizophrenia and was treated with Cogentin (View Usage). Patient experienced the following unwanted or unexpected effects: accommodation disorder, diplopia, pupillary reflex impaired, strabismus, visual acuity reduced. Cogentin dosage: Po. During the same period patient was treated with CYCLOBENZAPRINE HCL (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ), ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ), QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), ARIPIPRAZOLE (View Aripiprazole Review and Aripiprazole Label ).


6213873-7 | Anger, Aphasia, Cognitive Disorder, Confusional State, Dizziness, Headache, Impaired Work Ability, Memory Impairment, Tremor
on Jun 02, 2009 Female patient from UNITED STATES , 60 years of age, weighting 180.0 lb, was diagnosed with akathisia and was treated with Cogentin (View Usage). Patient had the following side effects: anger, aphasia (What is aphasia?), cognitive disorder, confusional state, dizziness (What is dizziness?), headache (What is headache?), impaired work ability, memory impairment, tremor. Cogentin dosage: Smallest Dosage 3x/day Po.

6207359-3 | Accommodation Disorder, Diplopia, Overdose, Strabismus, Visual Acuity Reduced
Patient was taking Cogentin (View Usage). After Cogentin was administered, patient had the following side effects: accommodation disorder, diplopia, overdose, strabismus, visual acuity reduced on May 08, 2009 from UNITED STATES Additional patient health information: Female patient , 29 years of age, was diagnosed with depression (What is depression?), schizophrenia and. Cogentin dosage: . During the same period patient was treated with CYCLOBENZAPRINE HCL (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ), ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ), QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), ARIPIPRAZOLE (View Aripiprazole Review and Aripiprazole Label ).

5919041-8 | Confusional State, Dysphagia, Hypoaesthesia, Muscle Contractions Involuntary, Tremor
Adverse event was reported on Oct 14, 2008 by a Female patient taking Cogentin (View Usage) (Dosage: 0.5 Mg. Twice Daily Po) was diagnosed with muscle contractions involuntary, tremor and. Location: UNITED STATES , 59 years of age, weighting 96.00 lb, Patient experienced the following unwanted or unexpected effects: confusional state, dysphagia, hypoaesthesia, muscle contractions involuntary, tremor. During the same period patient was treated with PEOVIGIL (View Peovigil Review and Peovigil Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), SEROQUEL (View Seroquel Review and Seroquel Label ).

5642592-0 | Heart Rate Increased, Palpitations
on Feb 27, 2008 Male patient from UNITED STATES , weighting 214.0 lb, was treated with Cogentin (View Usage). Patient had the following side effects: heart rate increased, palpitations. Cogentin dosage: . During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), HALDOL (View Haldol Review and Haldol Label ). Patient was hospitalized.

5247226-5 | Red Cell Distribution Width Increased, Thrombocythaemia
on Feb 06, 2007 Male patient from UNITED STATES , 48 years of age, was treated with Cogentin (View Usage). After Cogentin was administered, patient had the following side effects: red cell distribution width increased, thrombocythaemia. Cogentin dosage: . During the same period patient was treated with RISPERIDONE (Q2w; Im) (View Risperidone Review and Risperidone Label ), DEPAKOTE (View Depakote Review and Depakote Label ).

5115588-5 | Dementia
Patient was taking Cogentin (View Usage). Patient experienced the following unwanted or unexpected effects: dementia (What is dementia?) on Sep 14, 2006 from UNITED STATES Additional patient health information: Female patient , 88 years of age, . Cogentin dosage: .

5103972-5 | Dementia
Adverse event was reported on Aug 25, 2006 by a Female patient taking Cogentin (View Usage) (Dosage: ) . Location: UNITED STATES , 88 years of age, Patient had the following side effects: dementia (What is dementia?).

5034814-4 | Vision Blurred
on Apr 18, 2005 Female patient from UNITED STATES , child 8 years of age, was diagnosed with extrapyramidal disorder and was treated with Cogentin (View Usage). After Cogentin was administered, patient had the following side effects: vision blurred. Cogentin dosage: 0.5 Mg/daily/po.

4951903-0 | Dystonia
on Jan 05, 2006 Female patient from UNITED STATES , 41 years of age, was diagnosed with dystonia (What is dystonia?), gastrointestinal infection and was treated with Cogentin (View Usage). Patient experienced the following unwanted or unexpected effects: dystonia (What is dystonia?). Cogentin dosage: . During the same period patient was treated with DROPERIDOL (View Droperidol Review and Droperidol Label ), DIPHENHYDRAMINE HYDROCHLORIDE (View Diphenhydramine Hydrochloride Review and Diphenhydramine Hydrochloride Label ), TRIHEXYPHENIDYL HYDROCHLORIDE (View Trihexyphenidyl Hydrochloride Review and Trihexyphenidyl Hydrochloride Label ), COMPAZINE (View Compazine Review and Compazine Label ).

4921035-6 | Adverse Event, Hospitalisation
Patient was taking Cogentin (View Usage). Patient had the following side effects: adverse event, hospitalisation on Feb 15, 2006 from UNITED STATES Additional patient health information: Female patient , 87 years of age, was diagnosed with dementia alzheimer's type and. Cogentin dosage: . During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ), DEPAKOTE (View Depakote Review and Depakote Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), EXELON (View Exelon Review and Exelon Label ), NAPROXEN (View Naproxen Review and Naproxen Label ). Patient was hospitalized.

4880732-1 | Anxiety, Dyskinesia, Dystonia, Fatigue, Neck Pain, Throat Tightness
Adverse event was reported on Jan 05, 2006 by a Female patient taking Cogentin (View Usage) (Dosage: ) was diagnosed with dystonia (What is dystonia?), gastrointestinal infection and. Location: UNITED STATES , 41 years of age, After Cogentin was administered, patient had the following side effects: anxiety (What is anxiety?), dyskinesia, dystonia (What is dystonia?), fatigue, neck pain, throat tightness. During the same period patient was treated with DROPERIDOL (View Droperidol Review and Droperidol Label ), DIPHENHYDRAMINE HYDROCHLORIDE (View Diphenhydramine Hydrochloride Review and Diphenhydramine Hydrochloride Label ), TRIHEXYPHENIDYL HYDROCHLORIDE (View Trihexyphenidyl Hydrochloride Review and Trihexyphenidyl Hydrochloride Label ).

4859998-X | Diarrhoea, Myoclonus, Pneumonia
on Dec 14, 2005 Female patient from UNITED KINGDOM , 44 years of age, was treated with Cogentin (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, myoclonus, pneumonia (What is pneumonia?). Cogentin dosage: . During the same period patient was treated with VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), TERAZOSIN HYDROCHLORIDE (View Terazosin Hydrochloride Review and Terazosin Hydrochloride Label ), CLOZAPINE (View Clozapine Review and Clozapine Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

4775822-8 | Completed Suicide
on Sep 13, 2005 Female patient from UNITED STATES , 38 years of age, was treated with Cogentin (View Usage). Patient had the following side effects: completed suicide. Cogentin dosage: . During the same period patient was treated with SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ).

4775821-6 | Adverse Event
Patient was taking Cogentin (View Usage). After Cogentin was administered, patient had the following side effects: adverse event on Sep 13, 2005 from UNITED STATES Additional patient health information: Female patient , 59 years of age, . Cogentin dosage: . During the same period patient was treated with HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), ZIPRASIDONE HYDROCHLORIDE (View Ziprasidone Hydrochloride Review and Ziprasidone Hydrochloride Label ).

4775809-5 | Cardio-respiratory Arrest, Completed Suicide
Adverse event was reported on Sep 13, 2005 by a Female patient taking Cogentin (View Usage) (Dosage: ) . Location: UNITED STATES , 40 years of age, Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, completed suicide. During the same period patient was treated with VENLAFAXINE HYDROCHLORIDE (View Venlafaxine Hydrochloride Review and Venlafaxine Hydrochloride Label ), QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ).

4775164-0 | Completed Suicide
on Sep 13, 2005 Female patient from UNITED STATES , 39 years of age, was treated with Cogentin (View Usage). Patient had the following side effects: completed suicide. Cogentin dosage: . During the same period patient was treated with DOXEPIN HYDROCHLORIDE (View Doxepin Hydrochloride Review and Doxepin Hydrochloride Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ).

4775162-7 | Completed Suicide
on Sep 13, 2005 Female patient from UNITED STATES , 49 years of age, was treated with Cogentin (View Usage). After Cogentin was administered, patient had the following side effects: completed suicide. Cogentin dosage: . During the same period patient was treated with ZIPRASIDONE HYDROCHLORIDE (View Ziprasidone Hydrochloride Review and Ziprasidone Hydrochloride Label ), MEMANTINE (View Memantine Review and Memantine Label ).

4762805-7 | Abortion Spontaneous
Patient was taking Cogentin (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous on Aug 30, 2005 from UNITED STATES Additional patient health information: Female patient , 39 years of age, was diagnosed with torticollis and. Cogentin dosage: . During the same period patient was treated with BOTOX (View Botox Review and Botox Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ).

4750520-5 | Agitation Postoperative, Asthenia, Cerebral Infarction, Confusion Postoperative, Delirium, Dysarthria, Dysphagia, Parkinsonism
Adverse event was reported on Aug 02, 2005 by a Male patient taking Cogentin (View Usage) (Dosage: 2 Mg/bid) was diagnosed with parkinsonism, confusional state and. Location: AUSTRALIA , 75 years of age, Patient had the following side effects: agitation postoperative, asthenia, cerebral infarction, confusion postoperative, delirium, dysarthria, dysphagia, parkinsonism. During the same period patient was treated with HEPARIN (See Image) (View Heparin Review and Heparin Label ), HALOPERIDOL (10 Mg/1x) (View Haloperidol Review and Haloperidol Label ). Patient was hospitalized and became disabled.

4744778-6 | Hallucination, Auditory
on Aug 12, 2005 Female patient from UNITED STATES , weighting 115.0 lb, was diagnosed with extrapyramidal disorder and was treated with Cogentin (View Usage). After Cogentin was administered, patient had the following side effects: hallucination, auditory. Cogentin dosage: 2 Mg Bid Oral. During the same period patient was treated with REGLAN (View Reglan Review and Reglan Label ).

4704628-0 | Aggression, Tremor
on Jun 27, 2005 Male patient from , 33 years of age, was diagnosed with schizophrenia and was treated with Cogentin (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, tremor. Cogentin dosage: . During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ). Patient was hospitalized.

4686885-2 | Aggression, Tardive Dyskinesia
Patient was taking Cogentin (View Usage). Patient had the following side effects: aggression, tardive dyskinesia on Jun 01, 2005 from Additional patient health information: Male patient , 16 years of age, . Cogentin dosage: . During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ), DEPAKOTE (View Depakote Review and Depakote Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), CLARITIN D (View Claritin-d Review and Claritin-d Label ). Patient was hospitalized.

4618358-7 | Constipation, Intestinal Obstruction
Adverse event was reported on Mar 17, 2005 by a Male patient taking Cogentin (View Usage) (Dosage: ) was diagnosed with schizophrenia and. Location: , 43 years of age, After Cogentin was administered, patient had the following side effects: constipation (What is constipation?), intestinal obstruction. During the same period patient was treated with CLOZAPINE (View Clozapine Review and Clozapine Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LEXAPRO (View Lexapro Review and Lexapro Label ). Patient was hospitalized.